Our mission is to provide support to patients by enabling access to novel anti-cancer therapeutics through clinical research and engage in philanthropic initiatives to deliver patient support services and clinical trials.
Icon Cancer Foundation was founded in 1990 as the HOCA Research Centre. Its focus was simple; support the development of new and improved medications for patients in our care via clinical trials. More than twenty five years later our purpose remains the same, with an added focus on supporting patients participating in trials.
Today Icon Cancer Foundation is the largest private provider of cancer related clinical trials in Australia. Every day we strive to bring patients onto clinical trials in the hope this will give them the most valuable gift, a chance at extending their life. We conduct trials across both haematology [blood and bone marrow] and oncology [cancer] settings, including both medical oncology and radiation oncology. Through clinical trials we aim to provide more Australians with access to new approved treatments and continue to improve the future of cancer care.
Our specialised research team have developed partnerships with pharmaceutical companies, researchers and research organisations to deliver first-class coordination of cancer clinical trials.
As a not-for-profit registered charity, Icon Cancer Foundation uses funds raised to support patients on clinical trials who may have otherwise not been able to participate. This includes transport and accommodation support along with access to personal cancer care coordinators and allied health services to ensure patients achieve the best possible outcome from their trial.
To learn more about us, please visit the page ‘what we do’.